Trial NCT03982173

View at ClinicalTrials.gov 
Org. Study IDs: 2018-003115-21
Secondary IDs: 2018/2798

Last trial update was posted on 2023-01-26

MeSH Interventions

Durvalumab Tremelimumab

MeSH Conditions

Adenocarcinoma Triple Negative Breast Neoplasms

Other Conditions

Esophageal Adenocarcinoma Metastatic Colorectal Cancer Prostate Adenocarcinoma Stomach Adenocarcinoma Triple Negative Breast Cancer

Stopping Reasons

Similar clinical trials showed not very encouraging results, which made us decide, after several modifications to the protocol and numerous difficulties encountered, to abandon the trial.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID